Showing posts with label 5-alpha reductase inhibitors. Show all posts
Showing posts with label 5-alpha reductase inhibitors. Show all posts

Saturday, January 28, 2012

Drug May Slow Early Prostate Cancer: Study

In continuation of my update on Dutasteride (Avodaart)

New research suggests that Avodart, a drug used to treat an enlarged prostate gland, may help slow the progression of early stage prostate cancer, reducing the need for aggressive treatment in some men. 

Avodart belongs to a class of drugs called 5-alpha reductase inhibitors. These drugs work by interfering with the effects of certain male hormones on the prostate. In the three-year study, prostate cancer progressed in 38 percent of 144 men with early prostate cancer who were treated with Avodart and 48 percent of the 145 men who received a placebo....

More...